Sentences with phrase «stage breast cancer who»

Of the 1,551 women with early - stage breast cancer who were randomized to the comparison group of the WHEL study, more than half (864, or 56 percent) were taking tamoxifen, and more than three - quarters of those (674, or 78 percent) reported hot flashes.

Not exact matches

Backstage, Parker introduced Yee to Twitter co-founder Jack Dorsey and to Elizabeth Edwards — the wife of Sen. John Edwards — who had Stage 4 breast cancer and was donning a chic wig for the evening.

The study discovered that stage 3 and 4 breast cancer women who supplemented their diet with virgin coconut oil during breast cancer treatment improved fatigue, dyspnea, sleep difficulties, and loss of appetite compared to the control group.

«From speaking to the women who call our helpline Breast Cancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregBreast Cancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregCancer Care is aware of how traumatic a diagnosis of breast cancer can be at any stage of life, let alone during pregbreast cancer can be at any stage of life, let alone during pregcancer can be at any stage of life, let alone during pregnancy.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researcancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researCancer Center researchers.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

The study, published in Cancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagCancer, surveyed 1,006 women who were treated for early stage breast cancer and were employed at the time of their diagcancer and were employed at the time of their diagnosis.

A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves — despite the fact that knowing your genetic status may help catch the disease in its earliest stages.

Dr. Narod, who is also a Tier 1 Canada Research Chair in Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cCancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cancercancer:

For the study, researchers used a Medicare - linked database to identify women older than 65 who were diagnosed in 2000 - 09 with stage I - III breast cancer and received cancer treatments that previously had been linked to heart problems.

«This study demonstrates that Prosigna can reliably identify early stage breast cancer patients who have a low risk - of disease recurrence at 10 years, including a substantial proportion of patients with node - positive disease for whom the risk / benefit derived for adjuvant chemotherapy would be at best neutral,» said Dr. Alessandra Cesano, chief medical officer of NanoString Technologies.

Letrozole is approved by the FDA for the adjuvant treatment of early - stage breast cancer in postmenopausal women who have already been treated with 5 years of tamoxifen therapy.

SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andBreast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andCancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andbreast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 andcancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.

The researchers found that non-Hispanic white women were more likely to have smaller tumors, and more likely to have the less - aggressive HR + / HER2 - subtype of breast cancer, compared with African - American women, who were more likely to have large tumors, more likely to have the aggressive triple - negative breast cancer, and 40 to 70 percent more likely to be diagnosed at stage 4 of all subtypes of breast cancer.

Uninsured women with breast cancer were nearly 2.6 times more likely to have a late - stage diagnosis than cancer patients who were insured, finds a new study from the Brown School at Washington University in St. Louis.

Uninsured women with breast cancer were nearly 2.6 times more likely to have a late stage diagnosis than cancer patients who were insured, finds a new study from Kimberly Johnson, associate professor at the Brown School.

It's normal to start thinking of your most comforting casserole recipes to drop off at the home of someone with breast cancer, but «people do not realize that a lot of patients may have foods that they can not eat,» says Rebecca Scheinkman, 36, who was diagnosed in 2014 with stage 4 breast cancer.

«When someone is going through any illness, you immediately want to help,» says AnnMarie Otis, 45, who was diagnosed with stage 1 breast cancer at age 40.

The test signaled that Rancic, who has no family history of breast cancer, was in the early stages of the disease.

I also draw strength from a bracelet given to me by the daughter of a friend who passed away from stage 4 breast cancer.

By Patrick Sauer TUESDAY, Dec. 16, 2008 (Health.com)-- Women who have been treated for early - stage breast cancer may have a lower risk of recurrence if they eat a relatively low - fat diet that's rich in fruits, vegetables, and fiber, according to a study published Monday in the Journal of Clinical Oncology.

She then saw a different doctor, who ordered not only a mammogram and ultrasound but a biopsy; the tests turned up stage III metastatic breast cancer.

Stated differently: If a woman was diagnosed with stage 4 breast cancer and began ingesting 40 supplements daily, but died six months later, she would have been counted as being a heavy supplement user who died prematurely.»

One study conducted by researchers at Women's Healthy Eating and Living (WHEL) followed women who had completed treatment for early stage breast cancer, and found that women with the highest blood concentrations of carotenoids had the least likelihood of cancer recurrence.

I would love to win this basket for my beautiful sister in law who is 28 and battling stage 4 breast cancer!

Carol, who had been battling Stage 4 breast cancer since 2008, died in December 2014.

Zapharis has actually helped train dogs to detect early stage lung and breast cancers for two federally funded studies, as well as nine dogs who were trained to detect ovarian cancer.

Breslin & Breslin's medical malpractice team achieved a significant settlement on behalf of a client who suffered from Stage IV breast cancer after several misread mammograms and other tests by her gynecologist.

The survival rate of women who detect breast cancer early is similarly high; more than 90 percent of women who detect and treat breast cancer in its early stages will survive.

This Teachable Moment uses the case of a woman in her 30s undergoing chemotherapy for stage 2A breast cancer who was hospitalized for febrile neutropenia to illustrate the need to avoid overtreatment for low - risk patients with this common oncological complication.

I'd give it to my mom who is recovering from stage 4 breast cancer and needs all the hope she can get.